Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDProQR Therapeutics N.V Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.14 | -$0.10 | -$0.12 |
| Q2 2026 | 2 | -$0.15 | -$0.10 | -$0.12 |
| Q3 2026 | 2 | -$0.14 | -$0.08 | -$0.12 |
| Q4 2026 | 1 | -$0.15 | -$0.10 | -$0.13 |
| Q1 2027 | 1 | -$0.15 | -$0.10 | -$0.14 |
| Q2 2027 | 1 | -$0.18 | -$0.12 | -$0.16 |
| Q3 2027 | 1 | -$0.19 | -$0.13 | -$0.16 |
| Q4 2027 | 1 | -$0.23 | -$0.16 | -$0.20 |
ProQR Therapeutics N.V Earnings Date And Information
ProQR Therapeutics N.V last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-0.15 earnings per share for the quarter, missing analysts' consensus estimates of $-0.15 by $0. The company had revenue of 2.07 M for the quarter and had revenue of 15.28 M for the year. ProQR Therapeutics N.V has generated $0 earnings per share over the last year ($-0.38 diluted earnings per share) and currently has a price-to-earnings ratio of -3.77. ProQR Therapeutics N.V has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
ProQR Therapeutics N.V Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | -$0.15 | -$0.13 | 0.02 | $4.51 M | $2.07 M |
| 05/12/2026 | Q4 2025 | -$0.15 | -$0.09 | 0.06 | $5.64 M | $4.64 M |
| 11/06/2025 | Q3 2025 | -$0.10 | -$0.10 | 0 | $5.05 M | $2.92 M |
| 08/07/2025 | Q2 2025 | -$0.08 | -$0.12 | -0.04 | $5.17 M | $3.82 M |
| 05/08/2025 | Q1 2025 | -$0.09 | -$0.10 | -0.01 | $5.28 M | $4.52 M |
| 03/13/2025 | Q4 2024 | -$0.10 | -$0.11 | -0.01 | $5.00 M | $4.31 M |
| 11/07/2024 | Q3 2024 | -$0.12 | -$0.10 | 0.02 | $11.24 M | $3.84 M |
| 08/08/2024 | Q2 2024 | -$0.12 | -$0.03 | 0.09 | $11.44 M | $6.31 M |
| 05/09/2024 | Q1 2024 | -$0.12 | -$0.09 | 0.03 | $2.62 M | $4.45 M |
| 03/13/2024 | Q4 2023 | -$0.08 | -$0.07 | 0.01 | N/A | $3.28 M |
| 11/07/2023 | Q3 2023 | -$0.06 | -$0.07 | -0.01 | N/A | $1.37 M |
| 08/03/2023 | Q2 2023 | -$0.12 | -$0.10 | 0.02 | N/A | $1.24 M |
| 05/16/2023 | Q1 2023 | -$0.12 | -$0.10 | 0.02 | N/A | $697.00 K |
| 03/29/2023 | Q4 2022 | -$0.20 | -$0.14 | 0.06 | N/A | $1.21 M |
| 11/09/2022 | Q3 2022 | -$0.23 | -$0.34 | -0.11 | N/A | $888.00 K |
| 06/30/2022 | Q2 2022 | N/A | -$0.21 | N/A | N/A | $1.03 M |
| 05/05/2022 | Q1 2022 | -$0.25 | -$0.20 | 0.05 | N/A | $1.23 M |
| 04/29/2022 | Q4 2021 | N/A | -$0.26 | N/A | N/A | $444.00 K |
| 11/04/2021 | Q3 2021 | -$0.23 | -$0.22 | 0.01 | N/A | $1.16 M |
| 06/30/2021 | Q2 2021 | N/A | -$0.24 | N/A | N/A | $654.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ProQR Therapeutics N.V Earnings: FAQ's
The conference call for ProQR Therapeutics N.V's latest earnings report can be listened to online.
The conference call transcript for ProQR Therapeutics N.V's latest earnings report can be read online.
ProQR Therapeutics N.V (:PRQR) has a recorded annual revenue of $15.28 M.
ProQR Therapeutics N.V (:PRQR) has a recorded net income of $-40,519,110.ProQR Therapeutics N.V has generated $-0.38 earnings per share over the last four quarters.
ProQR Therapeutics N.V (:PRQR) has a price-to-earnings ratio of -3.77 and price/earnings-to-growth ratio is 0.13.